Natrox
Natrox® is an advanced wound care therapy developed in Cambridge that delivers continuous topical oxygen to accelerate healing in acute and chronic wounds.
About
Natrox® is a transformative therapy brought to market by Cambridge-based Inotec AMD to accelerate healing in the most challenging wounds.
Now recognised as a new global standard for treating acute and chronic wounds, Natrox® is setting a powerful benchmark: up to 90% of patients with complex wounds heal within 8–12 weeks. Patients around the world are already experiencing successful outcomes, and the company continues to secure reimbursement in key markets.
Natrox® is FDA 510(k) cleared, CE (IIb) marked, and reimbursed in several regions. The patented technology—developed at the University of Cambridge—extracts moisture from ambient air and converts it into oxygen, delivering pure humidified oxygen directly to the wound bed under any dressing at a continuous flow rate.
